C. Barrie
Directeur/Membre du Conseil chez NORAM LITHIUM CORP.
Fortune : 167 826 $ au 31/05/2024
Profil
C.
Tucker Barrie is currently a Director at Noram Lithium Corp.
He previously held positions as President, Chief Executive Officer & Director at Windfall Geotek, Inc., President & Chief Executive Officer at Noram Lithium Corp., and Vice President-Corporate Development at Mindesta, Inc. Barrie has a graduate degree from The University of Texas at Austin and a doctorate degree from the University of Toronto.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NORAM LITHIUM CORP
2,27% | 14/06/2024 | 2 022 000 ( 2,27% ) | 167 826 $ | 31/05/2024 |
Postes actifs de C. Barrie
| Sociétés | Poste | Début |
|---|---|---|
| NORAM LITHIUM CORP. | Directeur/Membre du Conseil | 05/04/2024 |
Anciens postes connus de C. Barrie
| Sociétés | Poste | Fin |
|---|---|---|
| WINDFALL GEOTEK INC. | Directeur Général | 15/06/2016 |
| NORAM LITHIUM CORP. | Directeur Général | - |
Mindesta, Inc.
 Mindesta, Inc. Pharmaceuticals: GenericHealth Technology Mindesta, Inc. provides drug delivery systems technology services through its wholly owned subsidiary CTT Pharmaceuticals, Inc. CTT Pharma is a developmental stage company which has had limited operations to date and it specializes in drug delivery systems technology within the pharmaceutical industry. Mindesta was founded on November 6, 1996 and is headquartered in Ottawa, Canada. | Corporate Officer/Principal | - |
Formation de C. Barrie
| University of Toronto | Doctorate Degree |
| The University of Texas at Austin | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| WINDFALL GEOTEK INC. | Non-Energy Minerals |
| NORAM LITHIUM CORP. | Non-Energy Minerals |
| Entreprise privées | 1 |
|---|---|
Mindesta, Inc.
Mindesta, Inc. Pharmaceuticals: GenericHealth Technology Mindesta, Inc. provides drug delivery systems technology services through its wholly owned subsidiary CTT Pharmaceuticals, Inc. CTT Pharma is a developmental stage company which has had limited operations to date and it specializes in drug delivery systems technology within the pharmaceutical industry. Mindesta was founded on November 6, 1996 and is headquartered in Ottawa, Canada. | Health Technology |
